Download video

The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD

226 views

Renal Research Institute

3 months ago

The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD

The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD

The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD
30:38
The Impact of GLP-1RA and SGLT2i on CKD Progression in Subjects with Diabetes | Peter Rossing, MD
by Renal Research Institute
Obesity as a risk factor of CKD progression: is there a role for GLP-1RA? | Peter Rossing, MD
26:35
Obesity as a risk factor of CKD progression: is there a role for GLP-1RA? | Peter Rossing, MD
by Renal Research Institute
CKD progression and its prevention: the practical use of GLP-1RA and SGLT2i I Thomas Ebert. MD
32:52
CKD progression and its prevention: the practical use of GLP-1RA and SGLT2i I Thomas Ebert. MD
by Renal Research Institute
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
7:43
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
by Harvard Medical School Continuing Education
GLP-1RA and SGLT2i – the cardiology perspective I Jonas Spaak, MD
29:54
GLP-1RA and SGLT2i – the cardiology perspective I Jonas Spaak, MD
by Renal Research Institute
The 2020 KDIGO CKD Guidelines in Diabetes - Prof. Hiddo L. Heerspink
57:12
The 2020 KDIGO CKD Guidelines in Diabetes - Prof. Hiddo L. Heerspink
by Africa Healthcare Network Fireside Chats
Vial Denial and the GLP-1 Shortage
40:40
Vial Denial and the GLP-1 Shortage
by A Pound of Cure
Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists
25:58
Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists
by Medtalks
A New Future for Rare Kidney Disease: One Teen's Journey with FSGS
4:46
A New Future for Rare Kidney Disease: One Teen's Journey with FSGS
by NephCure
What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS Trust
3:23
What are SGLT2 inhibitors - Chronic Kidney Disease | UHL NHS Trust
by Leicester's Hospitals
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
6:11
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists
by Harvard Medical School Continuing Education
#12 SGLT2i \/ MRAs \/ GLP1s, with Katherine Tuttle
23:14
#12 SGLT2i \/ MRAs \/ GLP1s, with Katherine Tuttle
by ERA - European Renal Association
EFL042 - Synergistic Effects of GLP-1 RAs and Exercise
44:35
EFL042 - Synergistic Effects of GLP-1 RAs and Exercise
by Endocrine Society
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
6:57
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
by Zero To Finals
Akankasha Goyal, MD: Evolving Role of SGLT2 Inhibitors
2:35
Akankasha Goyal, MD: Evolving Role of SGLT2 Inhibitors
by HCPLive
GLP-1 agonists and SGLT-2 inhibitors for treating adults with SCD and nephropathy
0:53
GLP-1 agonists and SGLT-2 inhibitors for treating adults with SCD and nephropathy
by VJHemOnc – Video Journal of Hematology \& HemOnc
Investigating the GLP-1 Receptor Pools Responsible for Mediating the Weight Loss and Glucose
4:29
Investigating the GLP-1 Receptor Pools Responsible for Mediating the Weight Loss and Glucose
by DPCPSI
The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors
58:29
The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors
by Clinical Updates
Trailer SGLT2i \/ MRAs \/ GLP1s
1:24
Trailer SGLT2i \/ MRAs \/ GLP1s
by ERA - European Renal Association